AstraZeneca has signed a research agreement worth more than US$5 billion with Chinese drugmaker CSPC Pharmaceutical Group, ...

Frontier IP announced on Friday that it has entered into a strategic partnership with property developer Abstract Mid-Tech to ...

Frontier IP, a specialist in commercialising intellectual property is working in partnership to create a novel innovation hub ...

AstraZeneca has signed an AI-led research agreement with China's CSPC Pharmaceutical Group worth up to $5.3 billion, which ...

“Straight out of the blocks,” he says, “Cambridge Wide Open Week has been a whirlwind of inspiring pitches, thought-provoking ...

Multinationals on China: China has set a GDP growth target of around 5% for 2025. How do you view this target and China’s ...

For all the attention on U.S.-China AI competition, new studies point to China’s rapid rise in biotechnology, especially for ...

The Cambridge Independent Business Awards 2025 are now open for entry. Following the success of our inaugural awards last year, we are delighted to announce that the search is now on for the best in ...

Headquartered in Cambridge, the United Kingdom, AstraZeneca boasts a diversified geographical footprint as well as a product portfolio with several blockbuster medicines. AstraZeneca now has 16 ...

(Alliance News) - EnSilica PLC on Wednesday noted the opening of its engineering hub in Cambridge, where the firm hopes to attract new recruits. EnSilica shares were up 11% at 35.96 pence each on ...